ExHeaLifeSpan

Company Overview

Snapshot

Founded in May 2026 by Eli Yaacoby, Ana Baroni, and Liwen Yaacoby, ExHeaLifeSpan operates with 1–10 employees. The company has raised $500,000 across one funding round. In July 2026, ExHeaLifeSpan secured Pre-Seed funding.

Business overview

ExHeaLifeSpan is a health technology company developing a non-invasive diagnostic platform to measure and track biological aging. Its core technology combines breath volatile organic compound (VOC) analysis with multi-omic data integration, including blood biomarkers, cognitive assessments, microbiome profiling, and biometric data from wearable devices. The platform aims to identify subclinical age-related physiological declines before symptoms manifest, providing longitudinal tracking of aging trajectories, assessing risk development, and evaluating the efficacy of longevity and medical interventions. The company operates within the Health Tech & Life Sciences sector, serving markets in North America.

Company Intelligence Q&A

When was ExHeaLifeSpan founded?

ExHeaLifeSpan was founded in May 2026.

What is ExHeaLifeSpan's primary focus?

ExHeaLifeSpan focuses on developing a non-invasive diagnostic platform to measure and track biological aging through breath volatile organic compound (VOC) analysis and multi-omic data integration.

Who are the founders of ExHeaLifeSpan?

The founders of ExHeaLifeSpan are Eli Yaacoby, Ana Baroni, and Liwen Yaacoby.

What is the company's employee count?

ExHeaLifeSpan has 1–10 employees.

What is ExHeaLifeSpan's total disclosed funding?

ExHeaLifeSpan has raised a total of $500,000. This was secured in a Pre-Seed funding round in July 2026.